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XXXARTICLE
Hippocampal volume and CDR-SB can predict 
conversion to dementia in MCI patients
O volume do hipocampo e a soma dos subitens da escala CDR podem predizer a 
conversão para a demência nos pacientes com comprometimento cognitivo leve
João Guilherme Fiorani Borgio1,2, Leonardo Baldaçara2, Walter dos Santos Moraes1, Acioly L. T. Lacerda2, Maria 
Beatriz Montaño3, Andrea Parolin Jackowski2, Sérgio Tufik1, Luiz Roberto Ramos3, Rodrigo Affonseca Bressan2
The most relevant challenge in dementia is the early identi-
fication of cases that would allow neuroprotective measures to 
delay or eventually prevent the onset of the illness. Mild cogni-
tive impairment (MCI) and cognitive impairment no demen-
tia (CIND) represent states of cognitive impairment, estimated 
by neuropsychological battery tests, with no sufficient crite-
ria to meet the diagnosis of dementia1. Despite the high rate 
of conversion to dementia, it is not know which patients will 
be demented. Several isolated variables have been evaluated as 
predictors of conversion but none has demonstrated good ac-
curacy2. The use of combined methods to better predict the risk 
of conversion is being developed in recent years3,4.
The identification of predementia states can be done 
by clinical criteria1 or by semi-structured interviews, as the 
Clinical Dementia Rating (CDR)5. Its Global Score may be 
0=normal, 0.5=questionable dementia (no dementia cogni-
tive impairment), 1=mild dementia, 2=moderate dementia 
and 3=severe dementia5. Individuals with CDR equal to 0.5 
have annual conversion rate of 20%6. The CDR sum of boxes 
scores (CDR-SB) may vary from 0 to 18 and enables a quanti-
tative evaluation of impairment. In a five-year study, the an-
nual conversion rates to CDR=1 (considered definite demen-
tia) were 6.8% to CDR-SB=0, 10% to CDR-SB=0.5, 1 or 1.5 and 
35.7% to CDR-SB=2, 2.5 or 37.
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ABSTRACT
Objective: To evaluate the combination of two factors: clinical dementia rating sum of boxes scores (CDR-SB) and hippocampal volume (HV) 
as predictors of conversion from mild cognitive impairment (MCI) to dementia. Methods: Twenty-eight individuals (9 normal and 19 with 
MCI) were classified according to their CDR sum of boxes scores into 3 groups. Results: The hippocampal volume was significantly lower 
in the high-risk group and in those who developed dementia after two years. The rate of conversion was crescent among the three groups. 
Conclusion: We were proposed an additional measurement of the hippocampal volume which may be helpful in the prognosis. However, we 
noted that the CDR-SB is a method as efficient as neuroimaging to predict dementia with the advantage of being a procedure for low cost 
and easy implementation, more consistent with public policy.
Key words: geriatric psychiatry, neuroimage, mild cognitive impairment.
RESUMO
Objetivo: Avaliar a combinação de dois fatores: clinical dementia rating sum of boxes scores (CDR-SB) e volume hipocampal (VH) como 
preditores de conversão de ditúrbio cognitivo leve (DCL) em demência. Método: Vinte e oito indivíduos (9 normais e 19 com DCL) foram 
classificados de acordo com a soma dos escores CDR-SB em 3 grupos. Resultados: O volume do hipocampo foi significativamente menor 
no grupo de alto risco e naqueles que desenvolveram demência depois de dois anos. A taxa de conversão foi crescente entre os três grupos. 
Conclusão: Propusemos uma medição adicional do volume do hipocampo que pode ser útil no prognóstico. No entanto, notou-se que a 
CDR-SB é um método tão eficiente quanto neuroimagem para prever demência com a vantagem de ser um processo de baixo custo e de 
fácil implementação, mais consistente com a política pública.
Palavras-Chave: psiquiatria geriátrica, neuroimagem, distúrbio cognitivo leve.
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Reduction in hippocampal volume (HV), measured by re-
gion of interest approach using magnetic resonance imaging 
(MRI), may be present in patients with MCI8. Longitudinal 
studies measuring hippocampal atrophy indicate existence 
of a continuum from normal aging to MCI and dementia spe-
cially Alzheimer’s disease (AD)9. Such methodology has been 
used in a Brazilian setting already10. Nowadays it is pointed 
as a predictor of conversion to dementia in MCI patients11.
The objective of this study was to evaluate the combina-
tion of two factors: CDR-SB and HV as predictors of conver-
sion from MCI to dementia.
METHODS
Subjects
The EPIDOSO study was the first community-based co-
hort study with elders in Brazil. It started in 1991, evaluat-
ing 1,667 individuals with 65 years and older, living in an ur-
ban district, in São Paulo city, whose main objective was to 
determine predictors of good health outcome12,13. In 1998, 
440 individuals, survivors from the original sample, begun 
following up in the Centro de Estudos do Envelhecimento 
(CEE). Another study selected, among the CEE sample, those 
with Mini-Mental Status Examination (MMSE) less than 26 
(n=108) and randomly assigned others 48 with MMSE ≥26. 
The 156 individuals entered a protocol that included CDR-
SB, MMSE and Alzheimer’s disease assessment scale-cogni-
tive subscale (ADAS-cog)14, which objective was to validate 
CDR for the diagnosis of dementia in Brazil15. Among that 
sample, we selected only individuals who had no demen-
tia at the initial evaluation (CDR=0 or 0.5), no formal coun-
ter indication to underwent MRI and had signed informed 
consent. Those were then divided into three groups, depend-
ing on their CDR-SB. Persons with CDR=0 (thus CDR-SB=0) 
were called “low-risk” group (LR), those with CDR=0.5 and 
CDR-SB=0.5, 1 or 1.5 were called “medium-risk” group (MR) 
and those with CDR=0.5 and CDR-SB=2, 2.5 or 3 were called 
“high-risk” group (HR).
Procedures
Individuals were submitted to brain MRI, within a max-
imum period of four months after the clinical and neuro-
psychological evaluation of the former study15. Volumetric 
MRI scans were performed with a GE 1.5 Tesla Unit (Sigma 
System, General Electric Medical Systems, Milwaukee, 
Wisconsin) running version 5.4 software. Head position was 
standardized16,. A three-dimensional spoiled gradient re-
called acquisition in the steady-state pulse sequence was 
used to obtain 124 contiguous images with slice thickness 
of 1.5 mm in the coronal plane for region-of-interest mea-
sures (echo time=5 milliseconds, repetition time=25 milli-
seconds, flip angle=40 degrees, acquisition matrix=256x192, 
number of excitations=1, field of vision=24 cm). After two 
years from the baseline, they were re-evaluated with CDR-
SB, MMSE and ADAS-cog in order to detect clinical demen-
tia (Global score of CDR≤1).
The imaging data were analyzed with Brains 2 software, 
which provides valid and reliable volume measurements of 
specific structures with a manually operated approach17. 
Trained and reliable raters, blind to subject information, 
traced the hippocampus manually using valid protocols18. All 
volumes were divided by intracranial volume.
All data were analyzed with the Statistical Package for 
the Social Sciences 13.0 for Windows (SPSS, Inc., Chicago, 
Illinois). The Mann-Whitney test was used for continuous 
data when comparing two groups and Kruskal-Wallis test 
for continuous data when comparing three or more groups. 
Association between the comparison groups and categorical 
variables was assessed with χ2 test.
RESULTS
Twenty-eight individuals met the selection crite-
ria. The proportion of women was 60.7%, mean age was 
81±5.3 years and scholarship with mean 8±3.8 years. The 
distribution among the groups was: 9 LR, 11 MR and 8 HR. 
The three groups did not differ in their socio-demographic 
characteristics (Table 1).
No subject had clinical abnormalities on axial proton 
density and T2-weighted images. Subjects completed  the 
scan without sedation or significant head movement. The HV 
was significantly smaller in HG, comparing to LR and MR 
(Kruskal-Wallis; p<0.001) (Table 1).
After two years, no subject from LR, 4 (36.4%) subjects from 
MR and 7 (87.5%) from HR developed dementia (χ2; p<0.001). 
Dividing the sample into two groups, those who developed de-
mentia (D-group) did not differ in gender, age and years of schol-
arship, compared to those who did not (ND-group) (Table  2). 
The D-group had mean HV smaller than the ND-group two 
years before the assessment (Mann Whitney; p=0.02).
Table 1. Demographic characteristics and results of the three groups and of converters and non-converters.
Low-risk (n=9) Medium-risk (n=11) High-risk (n=8) p-value
Women/Men (% of women) 6/3 (66) 5/6 (45) 6/2 (75) 0.38
Age in years (mean±SD) 81.0±5.0 80.0±4.8 82.5±6.6 0.45
Years of scholarship (mean ± SD) 8.2±3.5 8.0±4.4 7.6±3.7 0.92
HV (% of ICV) 0.283±0.033 0.260±0.037 0.212±0.014 <0.001
SD: standard deviation; HV: hippocampal volume; ICV: intracranial volume.
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DISCUSSION
The HV was smaller in the HR group, suggesting rela-
tionship between clinical performance and integrity of hip-
pocampus. The individuals who developed dementia had 
smaller HV at baseline, supporting that it may be a predic-
tor of conversion. Those results were expected and are sup-
ported by literature19.
Although the main outcome, diagnosis of dementia, 
had not followed the National Institute of Neurological and 
Communicative Diseases and Stroke/Alzheimer’s Disease 
and Related Disorders Association (NINCDS-ADRDA) crite-
ria20, and was made without investigation of its causes. The 
criterion of CDR=1 is quite sufficient to diagnose dementia, 
with wide use in recent studies21, as CDR=0.5 for CIND22, and 
is a valid instrument in our setting15,23.
Table 2. Demographic characteristics and results of converters and non-converters.
No-dementia (n=17) Dementia (n=11) p-value
Women/Men (% of women) 11/6 (65) 6/5 (54) 0.59
Age in years (mean±SD) 80.8±4.8 81.3±6.3 0.62
Years of scholarship (mean±SD) 7.9±3.8 8.0±4.0 0.83
HV (% of ICV) 0.266±0.038 0.239±0.039 0.02
SD: standard deviation; HV: hippocampal volume; ICV: Intracranial volume.
Brain MRI has been more commonly requested by clini-
cians to identify causes of dementia24, and CDR is already 
used in clinical practice in Brazil in order to dispense the an-
ticholinesterasic medication25. Thus, a simple modification in 
the standard evaluation of elders with cognitive complaints 
may be of great usefulness in predicting those that will con-
vert to dementia. We propose an additional measurement of 
the hippocampal volume which may be helpful in the prog-
nosis. However, we noted that the CDR-SB is a method as 
efficient as neuroimaging to predict dementia with the ad-
vantage of being a procedure for low cost and easy imple-
mentation, more consistent with public policy.
Further studies must evaluate the usefulness of this com-
bination in larger samples and the plausibility of combining 
more biological markers as risk factors to improve the pre-
dictive power to identify those who will convert to dementia.
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